At Aparito we’re involved in various projects across different study types including the development of novel digital endpoints, hybrid clinical trials and fully decentralised clinical trials.
1.
Operationalising
2.
Technology in Progress
3.
Live Study
4.
Completed Study
1
Operationalising
2
Technology in Progress
3
Live Study
4
Completed Study
Pivotal Regulated Study
Late Onset Pompe Disease (LOPD)
Gaucher Disease – Type 2
MPSIII (Sanfilippo Syndrome)
Ornithine transcarbamylase (OTC) deficiency
Cerebral Cavernous Malformation (CCM)
Osteogenesis Imperfecta
Batten Disease
Hypophosphatemia (XLH)
Angelman Syndrome
Long COVID
Inflammatory disease
Exploratory
Incontinence and Soiling
Pre-hab for Gynaecology Surgery
Gaucher Disease – Type 1
Neurodegenerative Disease in Adults
Dystonia (Sleep Quality)
Digital Endpoint Development
Amyotrophic Lateral Sclerosis (ALS)
Neurodegenerative Disease
Ataxia
Primary Ciliary Dyskinesia (PCD)
Duchenne Muscular Dystrophy
Proof of Concept / Feasibility Study
Juvenile Idiopathic Arthritis (JIA)
Niemann-Pick Disease Type C (NPC)
Paediatric Refractory Epilepsy
Leber Congenital Amaurosis (LCA)
Natural History Study
Late Onset GM2 Gangliosidosis
Global Disease Registry
Neuropathic Gaucher Disease
Ready to get started?
Share your study requirements and unlock the potential of Atom5™ for your clinical trial!